Daily FNArena News

With earnings momentum coming out of covid, Ramsay Health Care looks set to rebound from the pandemic downturn in surgeries, but the Spire acquisition raises questions over its balance sheet and funding options

Having examined the concept of additionality, FNArena checks out the impact horizon – the distant fields where additionality and impact-producing companies graze

While freight costs/delays, lockdowns and consumer behaviour continue to shadow progress, brokers are looking beyond the short-term pain to a continuation of The Reject Shop’s turnaround story beyond 2022

As 2021 is exposing many of the flaws and fragilities of the global shipping industry, disruption seems but the logical response. However, reforming the industry is far easier said than done

Analysts believe Commonwealth Bank is too expensive (they always do) while The Chartist sees further upside, but now is not the best time to get in.

Chinese tariffs have hit Treasury Wine Estates hard, but management is working even harder on a revised global strategy. Early optimism equally focuses on some kind of normalisation post covid

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. With a growth rate three times that of sector peers, Uniti Group is set to benefit from the scale afforded by recent acquisitions

Australian producers are well placed to contribute to lithium supply needed to feed unprecedented demand for electric vehicles over the coming decade

Michael Gable of Fairmont Equities notes that having lost favour in February-March, Afterpay rebounded but failed in April. It may be now ready for another go at $100

A glance through the latest expert views and predictions about commodities: gold; contractors; bulks; and steel